Trial run held at MMC&RI on 50 positive patients
New Delhi: An expert committee constituted by the Director General of Health Services, Ministry of Health and Family Welfare, Government of India, after careful evaluation, has recommended the use of ‘SwasthVayu’, a non-invasivebilevel positive airway pressure ventilator on COVID-19 patients who require oxygen supplementation up to 35 per cent.
Scientists along with medical professionals from Council of Scientific and Industrial Research-Indian Genomics and Integrative Biology (CSIR-IGIB) came forward to address shortages of ventilators in the beginning of Covid pandemic and indigenously designed and developed non-invasivebilevel positive airway pressure ventilator SwasthVayu, with additional features to treat Covid patients and make the country self-reliant.
Clinical trials at MMC&RI
The SwasthVayu has successfully conducted clinical trials at Mysore Medical College and Research Institute (MMC&RI) and Command Hospital, Bengaluru on 50 Covid patients each. The clinical trial reports clearly brought out that the performance of SwasthVayu ventilator device was satisfactory and effective in improving saturation during use for COVID-19 patients.
This post was published on January 6, 2021 6:21 pm